Panagora Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Panagora Asset Management’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-65,937	Closed	-$69K	–	2774
2019 Q1	$69K	Buy	65,937 +11,434	+21%	+$9.31K	﹤0.01%	1976
2018 Q4	$41K	Buy	54,503 +29,205	+115%	+$44K	﹤0.01%	2020
2018 Q3	$54K	Sell	25,298 -5,104	-17%	-$12.2K	﹤0.01%	2007
2018 Q2	$70K	Buy	+30,402	New	+$88.5K	﹤0.01%	1966
2017 Q3	–	Sell	-2,462	Closed	-$8K	–	2682
2017 Q2	$8K	Hold	2,462	–	–	﹤0.01%	2490
2017 Q1	$23K	Buy	+2,462	New	+$21.6K	﹤0.01%	2155
2016 Q2	–	Sell	-7,418	Closed	-$75K	–	2437
2016 Q1	$75K	Buy	+7,418	New	+$87.1K	﹤0.01%	1935

Panagora Asset Management's OMED Position: Q2 2019 in Review

Panagora Asset Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 65,937 shares — an estimated $69K sold.

Panagora Asset Management first reported a position in OMED in Q1 2016 and held it in 7 quarters. The position peaked at $75K in Q1 2016. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

Panagora Asset Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Panagora Asset Management sold 65,937 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $69K.
Panagora Asset Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2016 and held it in 7 quarters.
Panagora Asset Management's OncoMed Pharmaceuticals, Inc. position peaked at $75K in Q1 2016.
0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on Panagora Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.